SCHEMBL6530084

SCHEMBL6530084

COC(=O)[C@@H](CC(C)C)Nc1nc(Nc2cccc(F)c2)nc(-c2ccc(OC)cc2)n1

nearest known ligand 0.45

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
RORC P51449 8/20 0.45
KCNH3 Q9ULD8 2/20 0.43
CTSK P43235 1/20 0.42
DHFR P00374 1/20 0.42
ABCG2 Q9UNQ0 1/20 0.41
FPR2 P25090 1/20 0.41
SCN9A Q15858 1/20 0.41
ALDH1A1 P00352 1/20 0.41
CYP1A2 P05177 1/20 0.41
CYP2D6 P10635 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
CHRNA7 P36544 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6530078 1.00 RORC (0.45) RORCKCNH3CTSKDHFRABCG2
SCHEMBL8298689 0.88 CYP2C9 (0.44) KCNH3CTSKALDH1A1CYP1A2CYP2D6
SCHEMBL6528805 0.88 CYP2C9 (0.44) KCNH3CTSKALDH1A1CYP1A2CYP2D6
SCHEMBL6508189 0.87 KCNH3 (0.41) KCNH3CTSKALDH1A1CYP1A2CYP2D6
SCHEMBL6508192 0.87 KCNH3 (0.41) KCNH3CTSKALDH1A1CYP1A2CYP2D6
SCHEMBL6530423 0.86 ALDH1A1 (0.47) KCNH3CTSKALDH1A1CYP1A2CYP2D6
SCHEMBL6530426 0.86 ALDH1A1 (0.47) KCNH3CTSKALDH1A1CYP1A2CYP2D6
SCHEMBL6530469 0.85 NPR3 (0.55) KCNH3CYP1A2CYP2C9CYP2C19
SCHEMBL6530463 0.85 NPR3 (0.55) KCNH3CYP1A2CYP2C9CYP2C19
SCHEMBL6515009 0.81 ALDH1A1 (0.43) KCNH3CTSKALDH1A1CYP1A2CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005003103-A2 2, 4, 6-TRI-SUBSTITUTED 6-MEMBERED HETEROCYCLES AND THEIR USE IN THE TREATMENT OF NEURODEGENERATIVE DISEASES ASTRAZENECA AB (SE) 2005-01-13 WO claimed
WO-2005003103-A2 2, 4, 6-TRI-SUBSTITUTED 6-MEMBERED HETEROCYCLES AND THEIR USE IN THE TREATMENT OF NEURODEGENERATIVE DISEASES ASTRAZENECA AB (SE) 2005-01-13 WO disclosed